摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-bromo-2-(methoxymethoxy)-1-methylnaphthalene | 1415505-59-7

中文名称
——
中文别名
——
英文名称
3-bromo-2-(methoxymethoxy)-1-methylnaphthalene
英文别名
——
3-bromo-2-(methoxymethoxy)-1-methylnaphthalene化学式
CAS
1415505-59-7
化学式
C13H13BrO2
mdl
——
分子量
281.149
InChiKey
CJJAPLQCLOBZCN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    369.3±32.0 °C(Predicted)
  • 密度:
    1.385±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.1
  • 重原子数:
    16
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.23
  • 拓扑面积:
    18.5
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-bromo-2-(methoxymethoxy)-1-methylnaphthalene正丁基锂对甲苯磺酸 作用下, 以 乙醚乙醇正己烷 为溶剂, 反应 25.0h, 生成 3-(2-hydroxyethyl)-1-methylnaphthalen-2-ol
    参考文献:
    名称:
    Ammonium Hypoiodite-Catalyzed Peroxidative Dearomatization of Phenols
    摘要:
    Here, we report the first transition metal-free peroxidative dearomatization of phenols using hypoiodite catalysis with TBHP. Hypoiodite salts are generated in situ from the corresponding quaternary ammonium iodides in the presence of TBHP, and the oxidative coupling reaction proceeds efficiently under mild conditions. The dearomatized products are versatile synthetic intermediates for further synthetic transformations to various complex structures including heterocycles. As a demonstration, the further oxidation of the unsaturated peroxide with TBHP afforded the corresponding peroxy epoxide in good yield.
    DOI:
    10.3987/com-16-s(s)84
  • 作为产物:
    参考文献:
    名称:
    Iron-Catalyzed C-Allylating Partial Dearomatization of Naphthols
    摘要:
    The iron complex Bu4N[Fe(CO)(3)(NO)](TBA[Fe]) catalyzes the intermolecular allylation of naphthol derivatives to give the corresponding partially dearomatized allylated chromenones in good to excellent yields. The scope and limitations are reported. An efficient decarboxylative intramolecular C- allylation, starting from allyl naphthyl carbonates, was developed. From a mechanistic point of view, the overall process is the result of a fast O- allylation followed by a sigmatropic rearrangement to the desired product.
    DOI:
    10.1055/s-0035-1560909
点击查看最新优质反应信息

文献信息

  • [EN] PYRIMIDINE DERIVATIVES AS PGE2 RECEPTOR MODULATORS<br/>[FR] DÉRIVÉS DE PYRIMIDINE UTILISÉS EN TANT QUE MODULATEURS DES RÉCEPTEURS DES PGE2
    申请人:IDORSIA PHARMACEUTICALS LTD
    公开号:WO2018210988A1
    公开(公告)日:2018-11-22
    The present invention relates to pyrimidine derivatives of formula (I) wherein (R1)n, R3, R4a, R4b, R5a, R5b and Ar1 are as described in the description and their use in the treatment of cancer by modulating an immune response comprising a reactivation of the immune system in the tumor. The invention further relates to novel benzofurane and benzothiophene derivatives of formula (II) and their use as pharmaceuticals, to their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), and especially to their use as modulators of the prostaglandin 2 receptors EP2 and/or EP4.
    本发明涉及式(I)的嘧啶生物,其中(R1)n,R3,R4a,R4b,R5a,R5b和Ar1如描述中所述,以及它们通过调节免疫反应,包括肿瘤中免疫系统的再激活,用于治疗癌症。本发明进一步涉及新颖的苯并呋喃苯并噻吩生物式(II),及其作为药物的使用,其制备,药用可接受的盐,及其作为药物的使用,以及包含式(I)中一个或多个化合物的药物组合物,尤其是它们作为前列腺素2受体EP2和/或EP4的调节剂的使用。
  • Iron-Catalyzed Dioxygen-Driven C–C Bond Formation: Oxidative Dearomatization of 2-Naphthols with Construction of a Chiral Quaternary Stereocenter
    作者:Takuya Oguma、Tsutomu Katsuki
    DOI:10.1021/ja310203c
    日期:2012.12.12
    Iron(salan) complex 1 was found to catalyze the oxidative dearomatization of 1-substituted 2-naphthols with the formation of an all-carbon quaternary stereocenter in air in the presence of nitroalkanes, to afford the corresponding cyclic enones with high enantioselectivity of 88-96% ee.
  • PYRIMIDINE DERIVATIVES AS PGE2 RECEPTOR MODULATORS
    申请人:Idorsia Pharmaceuticals Ltd
    公开号:EP3625228A1
    公开(公告)日:2020-03-25
查看更多